Kellanova Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
The W.K. Kellogg Foundation Trust disposed of 45,097,438 shares of Kellanova common stock at $83.50 per share following the completion of a merger where Kellanova became a wholly-owned subsidiary.
Kellanova Director Roderick D. Gillum reports the disposition of common stock and phantom stock units following the company's merger into a wholly-owned subsidiary.
Kellanova director J Michael Schlotman reported the disposal of common stock at $83.50 per share following the company's merger into a wholly-owned subsidiary.
Kellanova director G. Zachary Gund disposed of common stock and phantom stock units following the company's merger into a wholly-owned subsidiary of Acquiror 10VB8, LLC at $83.50 per share.
Kellanova SVP-Chief Global Corporate Affairs, Kris Bahner, disposed of all common stock, restricted stock units, and stock options following the company's merger into a wholly-owned subsidiary.
Kellanova's Chairman and CEO, Steven A. Cahillane, converted all his equity holdings into cash following the company's merger into a wholly-owned subsidiary of Acquiror 10VB8, LLC at $83.50 per share.
Kellanova Director Donald R. Knauss disposed of over 61,000 common shares at $83.50 per share following the company's merger into a wholly-owned subsidiary.
Kellanova Director Stephanie Burns' equity holdings converted to cash following the company's merger with Acquiror 10VB8, LLC at $83.50 per share.
Senior Vice President Victor Marroquin converted all his Kellanova common stock, restricted stock units, performance-based restricted stock units, and stock options into cash following the company's merger.
Kellanova director Mary A. Laschinger reported the conversion of her common stock and phantom stock units into cash following the company's merger at $83.50 per share.
A Kellanova director reported the disposition of over 35,000 common shares at $83.50 each following the company's merger into a wholly-owned subsidiary.
Kellanova's Chief Legal Officer, Todd W. Haigh, disposed of common stock, restricted stock units, and stock options following the company's merger into a wholly-owned subsidiary, receiving $83.50 per share in cash.
Kellanova's Chief Financial Officer, John Renwick, reported the conversion of his equity holdings into cash following the company's merger into a wholly-owned subsidiary of Acquiror 10VB8, LLC at $83.50 per share.
A Kellanova Senior Vice President disposed of all common stock, restricted stock units, performance-based restricted stock units, and stock options following the company's merger, receiving $83.50 per share in cash.
Kellanova director Carolyn M. Tastad reported the disposal of all common stock holdings following the company's merger into a wholly-owned subsidiary.
Kellanova Senior Vice President Rodrigo Lance reports future dispositions of common stock, RSUs, PSUs, and stock options effective with the company's merger.
Kellanova Senior Vice President Shumit Kapoor converted all equity holdings, including common stock, RSUs, PSUs, and stock options, into cash following the company's merger with Acquiror 10VB8, LLC at $83.50 per share.
Kellanova Director Carter A. Cast disposed of all his direct beneficial ownership of common stock for $83.50 per share as part of a merger agreement.
Kellanova Senior Vice President David Lawlor disposed of all his common stock, restricted stock units, performance-based restricted stock units, and stock options for cash following the company's merger.
Kellanova director Erica L. Mann disposed of all her common stock holdings at $83.50 per share following the company's merger into a wholly-owned subsidiary.
Kellanova Senior Vice President Nicolas Amaya disposed of common stock, RSUs, PSUs, and stock options following the company's merger into a wholly-owned subsidiary of Acquiror 10VB8, LLC.
Kellanova's VP-Corporate Controller, Kurt D. Forche, reported the conversion and disposition of his equity holdings following the company's merger into a wholly-owned subsidiary.
Kellanova Senior Vice President Melissa A Howell disposed of all common stock, restricted stock units, and stock options following the company's merger at $83.50 per share.
Kellanova Director Stephanie Burns will acquire 158.02 phantom stock units on November 14, 2025, as part of the company's deferred compensation plan.
Kellanova Director G. Zachary Gund reported the acquisition of 316.04 phantom stock units, increasing his indirect beneficial ownership.
The W.K. Kellogg Foundation Trust executed a pre-planned sale of 114,599 shares of Kellanova common stock for approximately $9.1 million.
The W.K. Kellogg Foundation Trust, a 10% owner and director, has scheduled the sale of 114,583 shares of Kellanova common stock for August 21, 2025, for approximately $9.16 million.
Kellanova's Acting CFO, John Renwick, reported the vesting and subsequent tax-related sale of company stock on August 18, 2025.
Kellanova's Chief Legal Officer, Todd W. Haigh, exercised 5,803 restricted stock units and subsequently sold 2,351 shares to cover tax obligations.
Kellanova director G. Zachary Gund reported the acquisition of 327.82 phantom stock units, increasing his total beneficial ownership of such units to 22,775.686.